Company licensing deals database extracts
How to obtain crucial knowledge for benchmarking your potential licensing deals?
PharmaPlus owns a premium company-company financials database, which solely focuses on therapeutics licensing deals from 1996 until today. From this database PharmaPlus provides affordable customized company-company licensing deals database extracts.
A valuable intelligence tool for companies to support their upcoming licensing deal negotiations and their presentations to potential investors.
The database extracts solely display licensing deals for which at least one financial component (potential deal size, upfront, milestones, royalties, equity, research funding) is available. Almost 50% of the licensing deals in the database are early stage deals.
The easy to read database allows you to
- Benchmark your partnering deal terms
- Identify creative deal structures
- Identify companies partnering in your interest area
- Track competitor deal making activity
- Access detailed financial information
- Monitor deal trends in your areas of interest
- Gain insight into how big pharma structure their licensing deals
Our customized company-company deal financials extracts are provided at a minimum of 5 and a maximum of 25 licensing deals database.
For enquiries into deal financials on specific indications, compound classes, development status at time of deal closure, territories or any other criteria of interest to you, we invite you to contact us to discuss your enquiry.